Elevated DRD4 promoter methylation increases the risk of Alzheimer's disease in males

Molecular Medicine Reports

Volumn 14, Issue 3, 2016, Pages 2732-2738

  Ji, Huihui ^a   Wang, Yunliang ^b   Jiang, Danjie ^a   Liu, Guili ^a   Xu, Xuting ^a   Dai, Dongjun ^a   Zhou, Xiaohui ^c   Cui, Wei ^a   Li, Jinfeng ^b   Chen, Zhongming ^d   Li, Ying ^e   Zhou, Dongsheng ^d   Zha, Qin ^a   Zhuo, Renjie ^a   Jiang, Liting ^a   Liu, Yu ^a   Shen, Lili ^a   Zhang, Beibei ^a   Xu, Lei ^a   Hu, Haochang ^a   Zhang, Yuzheng ^b   Yin, Honglei ^b   Duan, Shiwei ^a   Wang, Qinwen ^a   more..

^a NINGBO UNIVERSITY   (China)

^b The 148 Central Hospital of PLA   (China)

^c XINJIANG MEDICAL UNIVERSITY   (China)

^d Ningbo Kangning Hospital   (China)

^e NINGBO FIRST HOSPITAL   (China)

Author keywords

Alzheimer's disease; DNA methylation; Dopamine receptor D4; Epigenetics; Male; Promoter

Indexed keywords

APOLIPOPROTEIN A; DONEPEZIL; DOPAMINE 4 RECEPTOR; RIVASTIGMINE; BIOLOGICAL MARKER; DRD4 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; ARTICLE; CHINA; CHOLINERGIC TRANSMISSION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MALE; PROMOTER REGION; PYROSEQUENCING; RISK FACTOR; SEX DIFFERENCE; VERY ELDERLY; BLOOD; CASE CONTROL STUDY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; PHENOTYPE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOMARKERS; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PHENOTYPE; PROMOTER REGIONS, GENETIC; RECEPTORS, DOPAMINE D4; SEX FACTORS;

EID: 84989173865     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.5560     Document Type: Article

References (67)

1. Wilson RS, Barnes LL, Mendes de Leon CF, Aggarwal NT, Schneider JS, Bach J, Pilat J, Beckett LA, Arnold SE, Evans DA and Bennett DA: Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 59: 364-370, 2002
2. Querfurth HW and LaFerla FM: Alzheimer's disease. N Engl J Med 362: 329-344, 2010
3. Kubota T: Epigenome: What we learned from Rett syndrome, a neurological disease caused by mutation of a methyl-CpG binding protein. Rinsho Shinkeigaku 53: 1339-1341, 2013 (In Japanese)
4. Alonso Vilatela ME, Lopez-Lopez M and Yescas-Gomez P: Genetics of Alzheimer's disease. Genetics of Alzheimer's disease 43: 622-631, 2012
5. Tang LL, Liu Q, Bu SZ, Xu LT, Wang QW, Mai YF and Duan SW: The effect of environmental factors and DNA methylation on type 2 diabetes mellitus. Yi Chuan 35: 1143-1152, 2013 (In Chinese)
6. Zhang W, Zheng Y and Hou L: Pharmacogenomic discovery delineating the genetic basis of drug response. Curr Genet Med Rep 1: 143-149, 2013
7. Wang T, Garcia JG and Zhang W: Epigenetic regulation in particulate matter-mediated cardiopulmonary toxicities: A systems biology perspective. Curr Pharmacogenomics Person Med 10: 314-321, 2012
8. Jiang D, Hong Q, Shen Y, Xu Y, Zhu H, Li Y, Xu C, Ouyang G and Duan S: The diagnostic value of DNA methylation in leukemia: A systematic review and meta-analysis. PloS One 9: e96822, 2014
9. Cheng J, Wang L, Xu L, Wang H, Liu P, Bu S, Ye M, Zhang L, Wang Q and Duan S: Gender-dependent miR-375 promoter methylation and the risk of type 2 diabetes. Exp Ther Med 5: 1687-1692, 2013
10. Tang LL, Liu Q, Bu SZ, Xu LT, Wang QW, Mai YF and Duan SW: The effect of environmental factors and DNA methylation on type 2 diabetes mellitus. Yi Chuan 35: 1143-1152, 2013 (In Chinese)
11. Xu L, Zheng D, Wang L, Jiang D, Liu H, Xu L, Liao Q, Zhang L, Liu P, Shi X, et al: GCK gene-body hypomethylation is associated with the risk of coronary heart disease. Biomed Res Int 2014: 151723, 2014
12. Jiang D, Zheng D, Wang L, Huang Y, Liu H, Xu L, Liao Q, Liu P, Shi X, Wang Z, et al: Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females. PloS One 8: e59752, 2013
13. Cheng J, Wang Y, Zhou K, Wang L, Li J, Zhuang Q, Xu X, Xu L, Zhang K, Dai D, et al: Male-specific association between dopamine receptor D4 gene methylation and schizophrenia. PloS One 9: e89128, 2014
14. Hodgson N, Trivedi M, Muratore C, Li S and Deth R: Soluble oligomers of amyloid-b cause changes in redox state, DNA methylation and gene transcription by inhibiting EAAT3 mediated cysteine uptake. J Alzheimers Dis 36: 197-209, 2013
15. Huihui Ji, Xiaohui Zhou, Zhongming Chen, Ying Li, Dongsheng Zhou, Renjie Zhuo, Shiwei Duan and Qinwen Wang: Research progress of DNA methylation in Alzheimer's disease. Chi J Cell Biol 36: 1551-1559, 2014
16. Al Akeel R: Role of epigenetic reprogramming of host genes in bacterial pathogenesis. Saudi J Biol Sci 20: 305-309, 2013
17. Fatemi M, Pao MM, Jeong S, Gal-Yam EN, Egger G, Weisenberger DJ and Jones PA: Footprinting of mammalian promoters: Use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level. Nucleic Acids Res 33: e176, 2005
18. Yu Z, Kong Q and Kone BC: Aldosterone reprograms promoter methylation to regulate αENaC transcription in the collecting duct. Am J Physiol Renal Physiol 305: F1006-F1013, 2013
19. Moen EL, Zhang X, Mu W, Delaney SM, Wing C, McQuade J, Myers J, Godley LA, Dolan ME and Zhang W: Genome-wide variation of cytosine modifications between European and African populations and the implications for complex traits. Genetics 194: 987-996, 2013
20. Moen EL, Stark AL, Zhang W, Dolan ME and Godley LA: The role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide. Mol Cancer Ther 13: 1334-1344, 2014
21. Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N, Waldman I, Fitzgerald M and Gill M: Dopaminergic system genes in ADHD: Toward a biological hypothesis. Neuropsychopharmacology 27: 607-619, 2002
22. Lin WY, Wu BT, Lee CC, Sheu JJ, Liu SH, Wang WF, Tsai CH, Liu HP and Tsai FJ: Association analysis of dopaminergic gene variants (Comt, Drd4 And Dat1) with Alzheimer s disease. J Biol Regul Homeost Agents 26: 401-410, 2012
23. Docherty SJ, Davis OS, Haworth CM, Plomin R, D'Souza U and Mill J: A genetic association study of DNA methylation levels in the DRD4 gene region finds associations with nearby SNPs. Behav Brain Funct 8: 31, 2012
24. Zhang H, Herman AI, Kranzler HR, Anton RF, Zhao H, Zheng W and Gelernter J: Array-based profiling of DNA methylation changes associated with alcohol dependence. Alcohol Clin Exp Res 37 (Suppl 1): E108-E115, 2013
25. Mill J and Heijmans BT: From promises to practical strategies in epigenetic epidemiology. Nat Rev Genet 14: 585-594, 2013
26. Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, Pace TW, Mercer KB, Mayberg HS, Bradley B, et al: Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nature Neurosci 16: 33-41, 2013
27. Provencal N, Suderman MJ, Guillemin C, Massart R, Ruggiero A, Wang D, Bennett AJ, Pierre PJ, Friedman DP, Côté SM, et al: The signature of maternal rearing in the methylome in rhesus macaque prefrontal cortex and T cells. J Neurosci 32: 15626-15642, 2012
28. Liu X, Zheng Y, Zhang W, Zhang X, Lioyd-Jones DM, Baccarelli AA, Ning H, Fornage M, He K, Liu K and Hou L: Blood methylomics in response to arsenic exposure in a low-exposed US population. J Expo Sci Environ Epidemiol 24: 145-149, 2014
29. Fiedler U, Wiltfang J, Peters N and Benninghoff J: Advances in the diagnostics of Alzheimer's disease. Nervenarzt 83: 661-673, 2012 (In German)
30. Doumas BT: Standards for total serum protein assays-A collaborative study. Clin Chem 21: 1159-1166, 1975
31. McPherson IG and Everard DW: Serum albumin estimation: Modification of the bromcresol green method. Clinic Chim Acta 37: 117-121, 1972
32. Yang X, Liu B, Sang Y, Yuan Y, Pu J, Liu Y, Li Z, Feng J, Xie Y, Tang R, et al: Kinetic analysis of the lactate-dehydrogenase-coupled reaction process and measurement of alanine transaminase by an integration strategy. Anal Sci 26: 1193-1198, 2010
33. Nath RL and Ghosh NK: A preliminary report on the determination of the normal values of serum alkaline phosphatase activity by velocity constant method. Bull Calcutta Sch Trop Med 10: 71-72, 1962
34. Zhang GH, Cong AR, Xu GB, Li CB, Yang RF and Xia TA: An enzymatic cycling method for the determination of serum total bile acids with recombinant 3alpha-hydroxysteroid dehydrogenase. Biochem Biophys Res Commun 326: 87-92, 2005
35. Roberts RF and Roberts WL: Performance characteristics of a recombinant enzymatic cycling assay for quantification of total homocysteine in serum or plasma. Clin Chim Acta 344: 95-99, 2004
36. Jaynes PK, Feld RD and Johnson GF: An enzymic, reaction-rate assay for serum creatinine with a centrifugal analyzer. Clin Chem 28: 114-117, 1982
37. Tabacco A, Meiattini F, Moda E and Tarli P: Simplified enzymic/colorimetric serum urea nitrogen determination. Clin Chem 25: 336-337, 1979
38. Whitlow K and Gochman N: Continuous-flow enzymic method evaluated for measurement of serum triglycerides with use of an improved lipase reagent. Clin Chem 24: 2018-2019, 1978
39. Knob M and Rosenmund H: Enzymic determination of total serum cholesterol with centrifugal analyzers (author's transl). Z Klin Chem Klin Biochem 13: 493-498, 1975 (In German)
40. Hunziker P and Keller H: A mechanized enzymic method for the determination of uric acid (author's transl). Z Klin Chem Klin Biochem 13: 89-96, 1975 (In German)
41. Asrow G: Semiautomated enzymic micro methods for blood glucose and lactic acid on a single filtrate. Anal Biochem 28: 130-138, 1969
42. Egloff M, Léglise D, Duvillard L, Steinmetz J, Boyer MJ, Ruelland A, Agher R and Beucler I: Multicenter evaluation on different analyzers of three methods for direct HDL-cholesterol assay. Ann Biol Clin (Paris) 57: 561-572, 1999
43. DaCol P and Kostner GM: Immunoquantification of total apolipoprotein B in serum by nephelometry: Influence of lipase treatment and detergents. Clin Chem 29: 1045-1050, 1983
44. Girault A, Loiseau D and Girault M: Quantitative determination of apolipoprotein A in human serum by laser nephelometry. Ric Clin Lab 11 (Suppl 2): S19-S29, 1981
45. Cazzolato G, Prakasch G, Green S and Kostner GM: The determination of lipoprotein Lp(a) by rate and endpoint nephelometry. Clin Chim Acta 135: 203-208, 1983
46. Deyo RA, Pope RM and Persellin RH: Interference by rheumatoid factor with the detection of C-reactive protein by the latex agglutination method. J Rheumatol 7: 279-287, 1980
47. Rifai N and Silverman LM: A simple immunotechnique for the determination of serum concentration of apolipoprotein E. Clin Chim Acta 163: 207-213, 1987
48. Ma J, Cheng J, Wang L, Wang H, Xu L, Liu P, Bu S, Zhang L, Le Y, Ye M, et al: No association between IRS-1 promoter methylation and type 2 diabetes. Mol Med Rep 8: 949-953, 2013
49. Zhang LN, Liu PP, Wang L, Yuan F, Xu L, Xin Y, Fei LJ, Zhong QL, Huang Y, Xu L, et al: Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension. PloS One 8: e63455, 2013
50. Zemek F, Drtinova L, Nepovimova E, Sepsova V, Korabecny J, Klimes J and Kuca K: Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine. Expert Opin Drug Saf 13: 759-774, 2014
51. Pritchard AL, Ratcliffe L, Sorour E, Haque S, Holder R, Bentham P and Lendon CL: Investigation of dopamine receptors in susceptibility to behavioural and psychological symptoms in Alzheimer's disease. Int J Geriatr Psychiatry 24: 1020-1025, 2009
52. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A and Winblad B: Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen Project, Stockholm. Neurology 48: 132-138, 1997
53. Penaloza CG, Estevez B, Han DM, Norouzi M, Lockshin RA and Zakeri Z: Sex-dependent regulation of cytochrome P450 family members Cyp1a1, Cyp2e1, and Cyp7b1 by methylation of DNA. FASEB J 28: 966-977, 2014
54. Piferrer F: Epigenetics of sex determination and gonadogenesis. Dev Dyn 242: 360-370, 2013
55. Siegmund KD, Connor CM, Campan M, Long TI, Weisenberger DJ, Biniszkiewicz D, Jaenisch R, Laird PW and Akbarian S: DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PloS One 2: e895, 2007
56. Paula-Lima AC, Tricerri MA, Brito-Moreira J, Bomfim TR, Oliveira FF, Magdesian MH, Grinberg LT, Panizzutti R and Ferreira ST: Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity. Int J Biochem Cell Biol 41: 1361-1370, 2009
57. Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG and Holtzman DM: Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Ann Neurol 48: 201-210, 2000
58. Emanuele E, Peros E, Tomaino C, Feudatari E, Bernardi L, Binetti G, Maletta R, Micieli G, Bruni AC and Geroldi D: Relation of apolipoprotein(a) size to alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 18: 189-196, 2004
59. Solfrizzi V, Panza F, D'Introno A, Colacicco AM, Capurso C, Basile AM and Capurso A: Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J Neurol Neurosurg Psychiatry 72: 732-736, 2002
60. Suszynska-Zajczyk J, Luczak M, Marczak L and Jakubowski H: Inactivation of the paraoxonase 1 gene affects the expression of mouse brain proteins involved in neurodegeneration. J Alzheimers Dis 42: 247-260, 2014
61. Nazef K, Khelil M, Chelouti H, Kacimi G, Bendini M, Tazir M, Belarbi S, El Hadi Cherifi M and Djerdjouri B: Hyperhomocysteinemia is a risk factor for Alzheimer's disease in an Algerian population. Arch Med Res 45: 247-250, 2014
62. Hosseinzadeh S, Dabidi Roshan V and Pourasghar M: Effects of intermittent aerobic training on passive avoidance test (shuttle box) and stress markers in the dorsal hippocampus of wistar rats exposed to administration of homocysteine. Iran J Psychiatry Behav Sci 7: 37-44, 2013
63. Lu YQ, Luo Y, He ZF, Chen J, Yan BL, Wang Y and Yu Q: Hydroxysafflor yellow A ameliorates homocysteine-induced Alzheimer-like pathologic dysfunction and memory/synaptic disorder. Rejuvenation Res 16: 446-452, 2013
64. Yarchoan M, Louneva N, Xie SX, Swenson FJ, Hu W, Soares H, Trojanowski JQ, Lee VM, Kling MA, Shaw LM, et al: Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease. J Neurol Sci 333: 9-12, 2013
65. Duong T, Nikolaeva M and Acton PJ: C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease. Brain Res 749: 152-156, 1997
66. Iwamoto N, Nishiyama E, Ohwada J and Arai H: Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: Immunohistochemical study using formic acid pretreatment of tissue sections. Neurosci Lett 177: 23-26, 1994
67. Ponnayyan Sulochana S, Sharma K, Mullangi R and Sukumaran SK: Review of the validated HPLC and LC-MS/MS methods for determination of drugs used in clinical practice for Alzheimer's disease. Biomed Chromatogr 28: 1431-1490, 2014